
Colleen Erin Snow
Examiner (ID: 14817, Phone: (571)272-8603 , Office: P/2899 )
| Most Active Art Unit | 2899 |
| Art Unit(s) | 2813, 2899 |
| Total Applications | 852 |
| Issued Applications | 644 |
| Pending Applications | 44 |
| Abandoned Applications | 177 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18056359
[patent_doc_number] => 20220387445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => PROSTACYCLIN ANALOGUE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/836120
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18241
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836120
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/836120 | PROSTACYCLIN ANALOGUE FORMULATIONS | Jun 8, 2022 | Abandoned |
Array
(
[id] => 20254817
[patent_doc_number] => 12427150
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-30
[patent_title] => Phospholipid formulations of 1'-cyano substituted carba-nucleoside analogs
[patent_app_type] => utility
[patent_app_number] => 17/824288
[patent_app_country] => US
[patent_app_date] => 2022-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16211
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17824288
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/824288 | Phospholipid formulations of 1'-cyano substituted carba-nucleoside analogs | May 24, 2022 | Issued |
Array
(
[id] => 17836496
[patent_doc_number] => 20220273801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 17/745662
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23672
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745662
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/745662 | COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATION | May 15, 2022 | Pending |
Array
(
[id] => 18169540
[patent_doc_number] => 20230036151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => ANTI-METHANOGENIC COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/742665
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30161
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17742665
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/742665 | ANTI-METHANOGENIC COMPOSITIONS AND USES THEREOF | May 11, 2022 | Abandoned |
Array
(
[id] => 18280892
[patent_doc_number] => 20230096364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/740698
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17740698
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/740698 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | May 9, 2022 | Abandoned |
Array
(
[id] => 17952412
[patent_doc_number] => 11478485
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-10-25
[patent_title] => Compositions and methods for treating CNS disorders
[patent_app_type] => utility
[patent_app_number] => 17/740673
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 30444
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17740673
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/740673 | Compositions and methods for treating CNS disorders | May 9, 2022 | Issued |
Array
(
[id] => 17805714
[patent_doc_number] => 20220257549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => METHOD FOR TREATMENT OF PARKINSON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/736494
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736494
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/736494 | Method for treatment of Parkinson's disease | May 3, 2022 | Issued |
Array
(
[id] => 19389332
[patent_doc_number] => 20240279202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING THE SAME METHODS OF THEIR MAKING AND METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 18/289513
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 124088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289513
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/289513 | COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING THE SAME METHODS OF THEIR MAKING AND METHODS OF THEIR USE | May 2, 2022 | Pending |
Array
(
[id] => 17981134
[patent_doc_number] => 20220347170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => Method of Reducing Brow Ache
[patent_app_type] => utility
[patent_app_number] => 17/730376
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730376
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/730376 | Method of Reducing Brow Ache | Apr 26, 2022 | Abandoned |
Array
(
[id] => 19816687
[patent_doc_number] => 20250074894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-06
[patent_title] => NITROPHENYL-ACRYLAMIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/555505
[patent_app_country] => US
[patent_app_date] => 2022-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10720
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18555505
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/555505 | NITROPHENYL-ACRYLAMIDES AND USES THEREOF | Apr 14, 2022 | Pending |
Array
(
[id] => 18225363
[patent_doc_number] => 20230064357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => METHOD FOR TREATMENT OF PARKINSON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/720777
[patent_app_country] => US
[patent_app_date] => 2022-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19805
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17720777
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/720777 | METHOD FOR TREATMENT OF PARKINSON'S DISEASE | Apr 13, 2022 | Abandoned |
Array
(
[id] => 19265226
[patent_doc_number] => 20240208925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => ISOQUINOLINE DERIVATIVES FOR USE AS ANTIVIRAL AND ANTITUMOUR AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/287011
[patent_app_country] => US
[patent_app_date] => 2022-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21159
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287011
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/287011 | ISOQUINOLINE DERIVATIVES FOR USE AS ANTIVIRAL AND ANTITUMOUR AGENTS | Apr 13, 2022 | Pending |
Array
(
[id] => 17759217
[patent_doc_number] => 20220232829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => DUAL ACTIVE INSECTICIDAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/715133
[patent_app_country] => US
[patent_app_date] => 2022-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6883
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17715133
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/715133 | Dual active insecticidal compositions | Apr 6, 2022 | Issued |
Array
(
[id] => 17944311
[patent_doc_number] => 20220331328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => 1-METHYLXANTHINE-BASED BIOACTIVE COMPOSITION AND METHOD OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/715911
[patent_app_country] => US
[patent_app_date] => 2022-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17715911
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/715911 | 1-methylxanthine-based bioactive composition and method of use thereof | Apr 6, 2022 | Issued |
Array
(
[id] => 19233693
[patent_doc_number] => 20240190885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 18/552482
[patent_app_country] => US
[patent_app_date] => 2022-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39574
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -91
[patent_words_short_claim] => 551
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552482
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552482 | KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | Mar 29, 2022 | Pending |
Array
(
[id] => 20328392
[patent_doc_number] => 12458649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Contraceptive compositions with reduced adverse effects
[patent_app_type] => utility
[patent_app_number] => 17/701588
[patent_app_country] => US
[patent_app_date] => 2022-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 20050
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17701588
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/701588 | Contraceptive compositions with reduced adverse effects | Mar 21, 2022 | Issued |
Array
(
[id] => 17702933
[patent_doc_number] => 20220202939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => PREPARATION FOR IMPROVING ACTIVITY AND/OR THERMAL STABILITY OF SUPEROXIDE DISMUTASE, AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/699204
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2345
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699204
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/699204 | PREPARATION FOR IMPROVING ACTIVITY AND/OR THERMAL STABILITY OF SUPEROXIDE DISMUTASE, AND APPLICATION THEREOF | Mar 20, 2022 | Abandoned |
Array
(
[id] => 19462320
[patent_doc_number] => 20240315989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => METHODS OF TREATING COVID-19
[patent_app_type] => utility
[patent_app_number] => 17/698361
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 78600
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -65
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17698361
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/698361 | METHODS OF TREATING COVID-19 | Mar 17, 2022 | Abandoned |
Array
(
[id] => 17718997
[patent_doc_number] => 20220211716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => ANTIVIRAL PRODRUGS AND NANOFORMULATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/655483
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17655483
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/655483 | Antiviral prodrugs and nanoformulations thereof | Mar 17, 2022 | Issued |
Array
(
[id] => 17685748
[patent_doc_number] => 20220193040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => Use of Isoxazoline Derivatives for the Treatment or Prevention of Arthropod Infestations in Poultry
[patent_app_type] => utility
[patent_app_number] => 17/653950
[patent_app_country] => US
[patent_app_date] => 2022-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653950
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/653950 | Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultry | Mar 7, 2022 | Issued |